BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29589318)

  • 1. Use of Organoids to Characterize Signaling Pathways in Cancer Initiation.
    Oatway C; Hirsch CL; Gregorieff A
    Methods Mol Biol; 2018; 1765():315-331. PubMed ID: 29589318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic reconstitution of tumorigenesis in primary intestinal cells.
    Onuma K; Ochiai M; Orihashi K; Takahashi M; Imai T; Nakagama H; Hippo Y
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11127-32. PubMed ID: 23776211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin Rescues Wnt-Driven Stem-like Phenotype in Human Intestinal Organoids and Increases the Wnt Antagonist Dickkopf-1.
    Dunbar K; Valanciute A; Lima ACS; Vinuela PF; Jamieson T; Rajasekaran V; Blackmur J; Ochocka-Fox AM; Guazzelli A; Cammareri P; Arends MJ; Sansom OJ; Myant KB; Farrington SM; Dunlop MG; Din FVN
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):465-489. PubMed ID: 32971322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
    Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
    Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors.
    Szvicsek Z; Oszvald Á; Szabó L; Sándor GO; Kelemen A; Soós AÁ; Pálóczi K; Harsányi L; Tölgyes T; Dede K; Bursics A; Buzás EI; Zeöld A; Wiener Z
    Cell Mol Life Sci; 2019 Jun; 76(12):2463-2476. PubMed ID: 31028424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
    Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
    Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
    Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
    Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC(Min/+) mice.
    Li Y; Teo WL; Low MJ; Meijer L; Sanderson I; Pettersson S; Greicius G
    Oncogene; 2014 Jan; 33(3):369-77. PubMed ID: 23318418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortcuts to intestinal carcinogenesis by genetic engineering in organoids.
    Maru Y; Onuma K; Ochiai M; Imai T; Hippo Y
    Cancer Sci; 2019 Mar; 110(3):858-866. PubMed ID: 30637899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Generation of Organoids for Studying Wnt Signaling.
    Drost J; Artegiani B; Clevers H
    Methods Mol Biol; 2016; 1481():141-59. PubMed ID: 27590160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer.
    Cristobal A; van den Toorn HWP; van de Wetering M; Clevers H; Heck AJR; Mohammed S
    Cell Rep; 2017 Jan; 18(1):263-274. PubMed ID: 28052255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protocol for lentiviral transduction and downstream analysis of intestinal organoids.
    Van Lidth de Jeude JF; Vermeulen JL; Montenegro-Miranda PS; Van den Brink GR; Heijmans J
    J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of intestinal organoids as tissue surrogates: cell composition and the epigenetic control of differentiation.
    Cao L; Kuratnik A; Xu W; Gibson JD; Kolling F; Falcone ER; Ammar M; Van Heyst MD; Wright DL; Nelson CE; Giardina C
    Mol Carcinog; 2015 Mar; 54(3):189-202. PubMed ID: 24115167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells.
    Yao R; Oyanagi J; Natsume Y; Kusama D; Kato Y; Nagayama S; Noda T
    Oncogene; 2016 Nov; 35(47):6109-6119. PubMed ID: 27157623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.